Goodkin K, Shapshak P, Metsch L R, McCoy C B, Crandall K A, Kumar M, Fujimura R K, McCoy V, Zhang B T, Reyblat S, Xin K Q, Kumar A M
Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, FL 33136, USA.
J Neuroimmunol. 1998 Mar 15;83(1-2):88-101. doi: 10.1016/s0165-5728(97)00225-7.
The epidemiology of cocaine abuse and potential relationships of cocaine withdrawal to human immunodeficiency virus type 1 (HIV-1)-associated dementia (HAD) are discussed. Neuroendocrinological changes in HIV-1 infection of the central nervous system (CNS) are discussed with the relevant impact of cocaine abuse. HIV-1 load in the brain tissue of infected substance users is described along with possible associations with neuropathology and HAD. Finally, the molecular epidemiology and sequence heterogeneity of HIV-1 and their implications for neuropathogenesis are summarized. The complex context of addressing cocaine abuse in the setting of HIV-1 infection appears more tractable when decomposed into its components.